Data / Drug companies / Kramer Novis
Kramer Novis: 28 products in the FDA NDC directory, labeler code 52083
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Kramer Novis (labeler code 52083) lists 28 products in the FDA National Drug Code Directory, covering 13 finished drugs by generic name. By type: 28 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 6, 2026.
The request: Watch Kramer Novis (FDA labeler code 52083): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 52083
- Products in commercial distribution
- 28
- Packages
- 34
- Finished drugs by generic name
- 13
- Prescription products
- 0
- Over the counter products
- 28
- Flagged as original packager
- 24 of 24 products that carry the flag
- Started marketing in the last 12 months
- 5
- Earliest marketing start
- August 17, 2010
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 28 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 28 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Dextromethorphan, guaifenesin, and phenylephrine | 2 | 1 |
| Acetaminophen, dexbrompheniramine maleate | 2 | 3 |
| Dextromethorphan hbr and guaifenesin | 2 | 17 |
| Guaifenesin, phenylephrine hcl,dextromethorphan hydrobromide | 2 | 1 |
| Dextromethorphan hbr ,guaifenesin ,phenylephrine hcl | 1 | 1 |
| Benzocaine, zinc chloride | 1 | 1 |
| Dextromethorphan hbr, guiafenesin, phenylephrine hcl | 1 | 1 |
| Dextromethorphan hydrobromide, glycerol guaiacolate | 1 | 1 |
| Guiafenesin, phenylephrine hcl | 1 | 1 |
| Zinc oxide | 1 | 595 |
| Undecylenic acid | 1 | 38 |
| Dextromethorphan hydrobromide, guaifenesin | 1 | 49 |
| Dextromethorphan hbr, guaifenesin | 1 | 67 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Syrup | 18 | 64.3% |
| Solution | 3 | 10.7% |
| Tablet | 2 | 7.1% |
| Solution/ drops | 2 | 7.1% |
| Spray | 1 | 3.6% |
| Cream | 1 | 3.6% |
| Liquid | 1 | 3.6% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| G-supress dx pediatric drops | 52083-651 | Syrup | Over the counter monograph drugs | October 6, 2026 |
| Supress dx pediatric drops | 52083-051 | Syrup | Over the counter monograph drugs | October 6, 2026 |
| G-dologen | 52083-683 | Tablet | Over the counter monograph drugs | December 15, 2025 |
| Dologen | 52083-483 | Tablet | Over the counter monograph drugs | December 15, 2025 |
| Tusslin | 52083-624 | Syrup | Over the counter monograph drugs | December 3, 2025 |
| Dermogen | 52083-680 | Cream | Over the counter monograph drugs | April 4, 2016 |
| Gencontuss | 52083-650 | Solution | Over the counter monograph drugs | June 8, 2015 |
| Pecgen dmx | 52083-630 | Solution | Over the counter monograph drugs | April 1, 2015 |
| Desgen dm | 52083-646 | Solution | Over the counter monograph drugs | October 18, 2014 |
| Sorbugen | 52083-660 | Syrup | Over the counter monograph drugs | October 8, 2014 |
| Gumsol | 52083-714 | Spray | Over the counter monograph drugs | February 28, 2014 |
| Desgen Pediatric | 52083-641 | Solution/ drops | Over the counter monograph drugs | January 27, 2014 |
| Myco Nail A Antifungal Solution | 52083-242 | Liquid | Over the counter monograph drugs | January 14, 2014 |
| SUPRESS-PE Pediatric | 52083-056 | Solution/ drops | Over the counter monograph drugs | January 14, 2014 |
| Supress DM | 52083-058 | Syrup | Over the counter monograph drugs | October 2, 2013 |
| G-zyncof | 52083-600 | Syrup | Over the counter monograph drugs | December 3, 2012 |
| G-tusicof | 52083-639 | Syrup | Over the counter monograph drugs | September 24, 2012 |
| Supress a | 52083-057 | Syrup | Over the counter monograph drugs | August 1, 2012 |
| Zyncof | 52083-400 | Syrup | Over the counter monograph drugs | June 1, 2011 |
| G-Supress DX | 52083-655 | Syrup | Over the counter monograph drugs | March 29, 2011 |
| Presgen B | 52083-637 | Syrup | Over the counter monograph drugs | March 29, 2011 |
| Tussi Pres B | 52083-237 | Syrup | Over the counter monograph drugs | March 29, 2011 |
| Supress DX Pediatric Drops | 52083-055 | Syrup | Over the counter monograph drugs | March 29, 2011 |
| Presgen | 52083-632 | Syrup | Over the counter monograph drugs | March 28, 2011 |
| Tussi Pres | 52083-231 | Syrup | Over the counter monograph drugs | March 28, 2011 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.